홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
NRXP
#4083
NRX Pharmaceuticals, Inc. Common Stock
2.500
0
USD
+9.65%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+9.65%
월간 변동
+29.53%
6달 변화
+40.45%
년간 변동율
+40.45%
이전 종가
2.280
0
Open
2.500
0
Bid
Ask
Low
2.500
0
High
2.500
0
양
40
마켓
주식
헬스케어
NRXP
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2025
TTM
Key stats
Total common shares outstanding
6.66 M
7.16 M
9.57 M
16.92 M
33.07 M
—
Valuation ratios
Enterprise value
290.94 M
66.53 M
52.32 M
42.35 M
82.45 M
288.25 M
Price to earnings ratio
-2.41
-2.02
-1.25
-0.93
-2.03
-6.75
Price to sales ratio
1 853.44
—
—
—
47.35
—
Price to cash flow ratio
-5.95
-2
-1.75
-2.2
-4.11
-20.82
Price to book ratio
10.78
10.74
-3.22
-1.01
-3.64
-5.37
EBITDA 비율에 대한 기업 가치
-2.52
—
—
-1.93
-5.03
—
Profitability ratios
Return on assets %
-2.84
-1.54
-4.12
-6.88
-2.21
-4.73
Return on equity %
-4.47
-5.37
2.57
1.08
1.8
0.92
Return on invested capital %
-5 927.61
-1 836.06
-1 184.05
-631.58
-353.51
-245.62
Gross margin %
100
—
—
—
58.78
—
Operating margin %
-95.7 K
—
—
—
-1 324.41
—
EBITDA margin %
-95.6 K
—
—
—
-1 326.86
—
Net margin %
-76.91 K
—
—
—
-2 336.49
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.74
1.66
0.36
0.15
0.31
0.94
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
—
—
0
0.15
0.09
Solvency ratios
Debt to assets ratio
—
—
1.25
1.8
0.05
3.96
Debt to equity ratio
—
—
-0.78
-0.28
-0.04
-1.06
Long term debt to total assets ratio
—
—
1.25
1.8
0
3.89
Long term debt to total equity ratio
—
—
-0.78
-0.28
0
-1.01
Per share metrics
Operating cash flow per share
-8.04
-6.04
-2.86
-1
-0.66
-0.44
EBIT per share
-24.65
—
—
-1.74
-0.76
-0.51
EBITDA per share
-24.65
—
—
-1.74
-0.76
-0.52
Total debt per share
—
—
1.21
0.62
0.03
0.86
Cash per share
5.88
3.05
0.61
0.14
0.36
0.71
Net current asset value per share
6.97
3.92
0.91
0.31
0.42
1.03
Tangible book value per share
4.43
1.13
-1.55
-2.18
-0.87
-3.5
Working capital per share
4.43
1.55
-1.61
-1.74
-0.92
-3.57
Book value per share
4.43
1.13
-1.55
-2.18
-0.74
-3.26
뉴스
NRx Pharmaceuticals, Inc. (NRXP) Surpasses Q4 Earnings Estimates
NRx Pharmaceuticals, Inc. (NRXP) Shareholder/Analyst Call Prepared Remarks Transcript
NRx Pharmaceuticals, FDA 생동성 승인 통지 받아
NRx Pharmaceuticals receives FDA bioequivalence approval notice
NRx Pharmaceuticals, FDA로부터 NRX-100 신약 승인 관련 지침 받아
NRx Pharmaceuticals receives FDA guidance on NRX-100 drug application
VTSAX vs. VTI: Which Vanguard Fund Should You Buy in 2026? - TipRanks.com
H.C. Wainwright, NRX 파마슈티컬 주가 목표 45달러로 상향
H.C. Wainwright raises NRx Pharmaceuticals stock price target to $45
NRx Pharmaceuticals appoints Joshua Brown as chief medical officer
NRx Builds Momentum From FDA Progress To Strategic Expansion - NRX Pharmaceuticals (NASDAQ:NRXP)
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—2/23/26 - TipRanks.com